Medicine

RSV Vaccines May Help Reduce Another Common Respiratory Virus

AI Insight

Researchers analyzed HMPV (human metapneumovirus) cases across 10 US regions and found that viral interference from RSV, rather than climate variables, best explains HMPV's seasonal patterns and timing. The study's transmission model showed that HMPV activity decreases when RSV is present, and only models incorporating this viral interference could reproduce the biennial epidemic patterns observed in some regions. Despite this interaction, the model predicts that RSV vaccines and interventions will not substantially increase HMPV cases.


This research suggests that ongoing RSV vaccination campaigns are unlikely to cause unintended increases in HMPV infections, addressing a key concern about viral competition when intervening against one respiratory pathogen. The findings improve understanding of HMPV seasonality and can inform better forecasting and public health planning for respiratory virus outbreaks.


⚠️ Preprint – Noch nicht peer-reviewed

Dieser Artikel wurde noch nicht von unabhängigen Experten begutachtet. Die Ergebnisse sind vorläufig und sollten mit Vorsicht interpretiert werden.

Human metapneumovirus (HMPV) causes acute lower respiratory infections, primarily affecting young children and older adults, with seasonal outbreaks peaking annually in March or April in the United States and other temperate regions in the Northern hemisphere. However, the factors driving HMPV seasonality in the United States remain poorly understood. We analyzed laboratory-confirmed HMPV cases and age-specific emergency department visits across 10 US regions, fitting an age-stratified dynamic transmission model to assess spatiotemporal patterns and investigate the influence of environmental variables and viral interference from RSV on HMPV transmission rates. We found that models incorporating climate variables into the transmission rate, including vapor pressure, precipitation, potential evapotranspiration, and minimum temperature, could not capture the timing of HMPV activity across all regions. Instead, HMPV timing was associated with RSV activity, with the HMPV transmission rate reduced in the presence of RSV. We showed that, unlike RSV, only models incorporating viral interference could reproduce the biennial pattern of HMPV observed in some regions, characterized by alternating late-small and early-large epidemics. Furthermore, our model successfully reproduced post-COVID-19 HMPV and RSV epidemics and predicted that RSV interventions are not likely to lead to a substantial increase in HMPV activity despite decreasing competition from RSV. Our work unravels the spatiotemporal dynamics of HMPV and its interaction with RSV, informing future seasonal forecasting and intervention strategies for HMPV.

Source: Spatiotemporal Dynamics of Human Metapneumovirus and Potential Impact of Respiratory Syncytial Virus Interventions in the United States